Meningitis Vaccines Market Forecast Specifies Prime Growth by 2025
Robust awareness programs, proactive government policies that include meningococcal vaccines in national immunization programs, and higher rate of prevalence of bacterial meningitis among infants has created a promising outlook for the meningitis vaccines market. Since decades, bacterial meningitis has been a serious cause of disability, mortality, and morbidity. Meningitis is caused by an infection which can be viral, bacterial, or fungal in nature. It causes inflammation of the brain and spinal cord membranes, and although urgent antibiotic treatments are available, meningitis continues to be a life-threatening disease.
Untreated
meningitis poses severe risk of death, with the infected person being
susceptible to permanent neurological disability. In this context, health
organizations strongly emphasize upon the administration of vaccines to prevent
the spread of meningitis. In the coming years, these factors are poised to open
favorable economic and business opportunities across the meningitis vaccines
market, particularly impacting collaboration within healthcare systems and
R&D initiatives.
Looking
For a Sample Copy of This Report? Request the Same Here: https://www.fairfieldmarketresearch.com/report/meningitis-vaccines-market/request-sample
Global Meningitis Vaccines Market: Major Market
Players
Prominent market players across the global
meningitis vaccines market include the Serum Institute of India (SII),
Chongqing Zhifei, GlaxoSmithKline Biologicals, Beijing Institute of Biological
Products Co., Ltd., Nuron Biotech, Pfizer, China National Biotech Group, and
Hualan Biological Bacterin Co., Ltd among others.
Strong R&D Initiatives, Public-Private
Collaboration Open New Growth Channels
Given
the life-threatening nature of meningitis, the scientific community is driven
to make vaccines with higher efficacy. At present, research studies pertaining
to the epidemiological and geographical characteristics of meningitis attract
the most interest from vaccine manufacturers. Several international
organizations have pledged to defeat meningitis by the end of this decade.
Moreover, both the public and private sector continue to strongly invest in
meningitis vaccination research, commissioning research grants and providing advanced
technologies and laboratories. Over the forecast period, these positive
commitments are expected to enhance the production of meningitis vaccines.
Besides, these developments are anticipated to better commercialize meningitis
vaccines, creating more awareness among people – this is projected to
substantially increase the demand for meningitis vaccines during the study
period.
Pediatric Segment Emerges as
Leading End-Use Segment in the Meningitis Vaccines Market
In terms of end-users, the meningitis vaccines market
can be segmented into pediatric and adult population. Incidence of bacterial
meningitis is higher among children, especially in Sub-Saharan Africa; improper
dosage of meningococcal vaccines put children at an increased risk of permanent
disability. Consequently, the pediatric segment is expected to witness the
fastest growth rate over the assessment period. Notably, the COVID-19 outbreak
has underscored the need for more comprehensive vaccination programs. This
factor is poised to strengthen healthcare infrastructures and national
vaccination initiatives, creating a favorable supply scenario for the
meningitis vaccines market. During the forecast period, the meningitis vaccines
market is likely to be challenged by issues in vaccine approval and bacterial
resistance to penicillin. However, sound research and collaborations are
expected to offer relief from these challenges.
North America Sustains Dominance
Across the Globe; China, India Rising Leaders
North
America holds the largest market share across the global meningitis vaccines
market. Over the forecast period, the region is set to maintain this dominance
due to the presence of major vaccine manufacturers, robust R&D, and sound
government support. Moreover, China and India continually develop new products
meet the worldwide meningitis vaccine demand through imports. Thus, the
meningitis vaccines market of these regions is projected to significantly
expand during the study period.
Do You Have Any Query or Specific Requirement?
Request Customization of Report: https://www.fairfieldmarketresearch.com/report/meningitis-vaccines-market/request-sample
About Us
Fairfield Market Research
is a UK-based market research provider. Fairfield offers a wide spectrum of
services, ranging from customized reports to consulting solutions. With a
strong European footprint, Fairfield operates globally and helps businesses navigate
through business cycles, with quick responses and multi-pronged approaches. The
company values an eye for insightful take on global matters, ably backed by a
team of exceptionally experienced researchers. With a strong repository of
syndicated market research reports that are continuously published &
updated to ensure the ever-changing needs of customers are met with absolute
promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20
30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
Follow Us: LinkedIn
Comments
Post a Comment